about
Immunosignaturing can detect products from molecular markers in brain cancerOver-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor TherapyExpression of genes controlling transport and catabolism of prostaglandin E2 in lipopolysaccharide feverThe ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant gliomaGene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger ageMathematical Analysis of Glioma Growth in a Murine Model.The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma ModelUsing ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.The ketogenic diet for the treatment of malignant glioma.Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.A network model of a cooperative genetic landscape in brain tumors.Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular targetProlonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic dietMonocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brainAnalysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons.Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays.Molecular biological determinants of meningioma progression and aggressive behavior.Monocyte-derived cells of the brain and malignant gliomas: the double face of Janus.In vitro biological dosimeter modeling of the glioblastoma response to radiation delivered by the Gamma Knife. Laboratory investigation.BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes.ATPS-77THE KETONE BODY ß-HYDROXYBUTYRATE RADIOSENSITIZES GLIOBLASTOMA MULTIFORME STEM CELLS.Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glED-39GANGLIOGLIOMA IN CHILDREN; IDENTIFICATION OF CASES AT RISK OF DEATH DUE TO PROGRESSION FOLLOWING INITIAL SURGERY.Metabolism and glioma therapy.Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas.Need for new review of article on ketogenic dietary regimes for cancer patients.Expression of a receptor protein tyrosine phosphatase in human glial tumors.ET-65THE KETOGENIC DIET REDUCES CARBONIC ANHYDRASE 9 AND ALTERS THE EXPRESSION OF PROTEINS INVOLVED WITH GLIOMA GROWTH AND PROGRESSION IN HYPOXIC CONDITIONS.The effect of high hydrostatic pressure on eukaryotic protein synthesisThe stability of rabbit reticulocyte polysomes at high hydrostatic pressureExpression of the tumor suppressor gene DCC in human gliomasImplicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue
P50
Q21134151-16FA044B-5783-41E2-9B8B-C0AFAF8BCF03Q25255455-07414CC5-76A2-4FEC-8B7B-656D8FC5E3C7Q28069398-7A1939C2-EC3A-435D-AE46-1083652C1F16Q28567884-24E1DB28-B0CA-494F-ABDB-050940CD2185Q28730187-D446E8D1-5142-4C55-ACE1-42972F110167Q33378354-3757D928-66BD-4EA6-8E40-56818E5CD23EQ33747076-1DE6827E-0460-40D4-BBC5-59659D7D5BC7Q34044274-35576515-6C67-4FDD-ACA9-03615BF8018CQ34090576-EEC3F590-B483-4583-B0CD-BF9C94164FB5Q34757474-9FDB33B5-ED53-4CE5-944D-0CFF16EF181AQ34952032-99ACC8B1-AC8F-4B06-89FC-9711E0DB8F39Q34992306-277BF601-DA34-4B1B-A1CF-7E0E13836AC8Q35127284-438453A5-EBCD-4CF3-A029-654E29650B74Q35649603-53695A7F-59C8-4E51-8578-8AEC148C9ACDQ36017728-10999A50-3D47-4517-B47C-907F933E3F49Q36283733-2E225329-7613-4344-9F35-9F6EA1CA8F93Q36911061-5519F691-9A73-4D10-B209-A61AA1F301AEQ37341271-4B88F01B-9265-4316-B0A5-DEB0217E2525Q37502005-A24DD028-1914-47CA-BA6B-D013881CF886Q38062326-2AEC0404-BD78-446D-8C9D-B7F9F8B8150CQ39623097-3FE33925-CEC5-43B0-9284-2A32A824F23AQ42805374-4F8A563D-4379-4CA0-8047-E410C8A315B1Q45830647-3B1AE287-CF65-47CB-BF03-F97A32951612Q46174903-1B857A9E-49F0-451C-8351-306A0C7B41D2Q47105669-6F3C9F6D-0E20-4B8F-A132-EEC6B041CE8FQ48394091-F452D5C5-CEAB-4CE9-94C5-2D65B25B7EA2Q48709366-17EDCDA1-F19F-4A0F-8196-03D5FF68733BQ53326526-DD6DA6C3-C872-4F94-829C-70794B995E06Q55477925-1B5ED23F-5131-4861-B737-2FD0BB01291EQ55547637-A275E4F1-1F14-430F-BD8B-84CEE5820645Q70472948-C9983E40-7638-4308-AFB8-39380C307BECQ70560252-06B95594-EF7F-4394-9F18-0493A0E9EB98Q72613235-8032276D-B913-4BEB-8375-720E92848A4EQ80148828-3C1B907A-9F5C-4839-A12B-A96680F2EB07
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3497-1895
@en
name
Adrienne C Scheck
@ast
Adrienne C Scheck
@en
Adrienne C Scheck
@nl
type
label
Adrienne C Scheck
@ast
Adrienne C Scheck
@en
Adrienne C Scheck
@nl
prefLabel
Adrienne C Scheck
@ast
Adrienne C Scheck
@en
Adrienne C Scheck
@nl
P106
P31
P496
0000-0003-3497-1895